Most Popular
Rising Stars: The Most Impactful IPOs of 2025
In 2025, over 200 companies went public on U.S. exchanges, but fewer than 25% surpassed the S&P 500’s 18% return. Notably, Karman (NYSE: KRMN), ...
Soybean Prices Rise on Thursday Morning
Soybean prices increased by 3 to 4 cents in early trading on Thursday, with the November contract closing at $10.06 1/2. The cmdtyView national ...
BSX Stock Poised for Growth with Acquisition of Valencia Technologies
Boston Scientific, Inc. (BSX) has entered a definitive agreement to acquire Valencia Technologies Corporation, which develops the FDA-approved eCoin System, an implantable device for ...
A Promising IPO Worth Considering for Long-Term Investment
Boston-based Aktis Oncology (NASDAQ: AKTS) debuted on the Nasdaq on January 9, 2026, raising $318 million, marking one of the largest biotech IPOs in ...
Managing AI Hype: How to Secure a 10.6% Dividend Amidst Market Concerns
Concerns regarding a potential AI bubble are being dismissed by key industry figures and hedge funds alike. Major CEOs, including those from Microsoft, Meta, ...
Big Tech’s Bold Move: Investing in Nuclear Stocks for Future Dominance
As of 2026, the tech sector is facing a significant energy bottleneck, shifting focus from computing power to reliable baseload electricity to support AI ...
Discover the Latest 13F Filers Investing in Costco
As of March 31, 2025, Costco Wholesale Corp (COST) was held by 16 hedge funds, according to recent 13F filings. These funds collectively reduced ...
NVIDIA Faces 1.4% Decline Due to China’s Block on H200 AI Chip Imports
NVIDIA Corporation (NVDA) saw its shares decline 1.4% on January 14, following reports that Chinese customs officials were instructed to block imports of its ...
Top Tech Stocks to Invest in for 2026
Key Points Alphabet (NASDAQ: GOOGL) and Meta Platforms (NASDAQ: META) are identified as leading tech stocks poised for significant growth in 2023. Alphabet is ...
MAIN Surpasses Average Analyst Expectations
Main Street Capital Corp (Symbol: MAIN) shares have surpassed the average analyst 12-month target price of $47.83, trading at $48.47. This milestone raises questions ...






